← Back to all trials
Not Yet Recruiting
NCT07430085
Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA
Conditions: Periarticular Block, Osteoarthritis (OA), Osteoarthritis (OA) of the Knee, Pain After Surgery, Knee Arthroplasty, Total
Sex: All
Ages: 18 Years – 89 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 150
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Summary
Prospective Cohort of patients who are scheduled for a Robot Assisted Total Knee Arthroplasty (RATKA). A prospective survey of patient reported outcome measures (Numeric Rating Scale) will be obtained postoperatively of 72 hours, as well as at the postoperative opioid consumption after 72 hours.
Eligibility Criteria
Inclusion Criteria:
Males or females aged 18-89 years
Diagnosed with knee osteoarthritis requiring surgical intervention
Indicated for unilateral RATKA
Exclusion Criteria:
Pediatric, pregnant, or incarcerated patients
BMI of more than 45 kg/m2
Prolonged opioid use history of \>5 mg/day for \>1 month
History of contralateral TKA \
Source: ClinicalTrials.gov (NCT07430085). StuddyBuddy aggregates publicly available trial information.
